What we found on the web about Nicvax
NicVAX is a nicotine conjugate vaccine intended to reduce or eliminate physical addiction to nicotine. According to the National Institute on Drug Abuse, NicVAX can potentially be used ...
NicVAX; Nicotine gum; Nicotine patch; Nicotine inhaler; Nicotine nasal spray; Psychoactive drug; Drug Discovery and Development: Nicotinic Acetylcholine Receptor Agonists
Rewiring the Brain against Addiction. Scientists are discovering brain chemistry that prevents, and reverses, addiction. By Jeffrey Helm, 1 Jun 2006, TheTyee ...
Even if NicVAX was shown to be effective in preventing and treating nicotine addiction, access to it might be limited. Experimental drugs such as NicVAX might not be covered ...
The goal of the NicVAX nicotine vaccine is to immunize people against nicotine addiction. After receiving a series of shots that encourage the body to build antibodies to nicotine ...
The purpose of this study is to determine whether vaccination with NicVAX will result in a higher continuous abstinence rate than vaccination with placebo in smokers who want to ...
Nabi Biopharmaceuticals (Nasdaq:NABI) announced today positive final results from its Phase 2 NicVAX(r) (Nicotine Conjugate Vaccine) schedule optimization immunogenicity study to ...
This press release is intended for business journalists and analysts/investors. Please note that this release may not have been issued in every market in which GSK operates.
It is projected that this nicotine vaccine by Nabi Biopharmaceuticals, if and after it is approved by the U.S. Food & Drug Administration, may become available sometime in 2012.
Other novel drugs are in development, but NicVax, by Nabi Biopharmaceuticals, a Boca Raton, Fla., biotech company with labs in Rockville, Md., is most advanced among the vaccines.
Here is what users have to say about Nicvax

NicVAX is a nicotine conjugate vaccine intended to reduce or eliminate physical addiction to nicotine. According to the National Institute on Drug Abuse, NicVAX can potentially be used to inoculate against addiction. This proprietary vaccine is being developed by Nabi Biopharmaceuticals with the aid of the University of Houston–Clear Lake and University of Minnesota. NicVAX consists of the hapten 3'-aminomethylnicotine which has been conjugated (attached) to Pseudomonas aeruginosa exoprotein A.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!